Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin W Bergmann

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
JACC. Case Reports|January 17, 2022
Atrial Giant Cell Myocarditis as a Cause of Heart Failure: Diagnostic Pathway and Successful TreatmentChristina Paitazoglou, Martin W Bergmann, Katharina Tiemann, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 3, 2014
Twelve-month results of the rapid renal sympathetic denervation for resistant hypertension using the OneShotTM ablation system (RAPID) studyStefan Verheye, John Ormiston, Martin W Bergmann, et al.
The Journal of Invasive Cardiology|July 2, 2017
Improved Algorithm for Ostium Size Assessment in Watchman Left Atrial Appendage Occlusion Using Three-Dimensional EchocardiographyMaximilian Schmidt-Salzmann, Felix Meincke, Felix Kreidel, et al.
American Heart Journal|June 20, 2017
The Assessment of the Watchman Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO) trialDavid R Holmes, Vivek Y Reddy, Maurice Buchbinder, et al.
The Biochemical Journal|January 27, 2010
Glucocorticoids inhibit IL-1beta-induced GM-CSF expression at multiple levels: roles for the ERK pathway and repression by MKP-1Robert Newton, Elizabeth M King, Wei Gong, et al.
JACC. Heart Failure|January 5, 2024
Treatment With an Interatrial Shunt in Heart Failure: 1-Year Outcomes of the PRELIEVE StudyChristina Paitazoglou, Martin W Bergmann, Baris Kilicaslan, et al.
European Journal of Heart Failure|December 22, 2009
MEF2 transcriptional activity maintains mitochondrial adaptation in cardiac pressure overloadHamid el Azzouzi, Ralph J van Oort, Roel van der Nagel, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 1, 2016
EWOLUTION: Design of a registry to evaluate real-world clinical outcomes in patients with AF and high stroke risk-treated with the WATCHMAN left atrial appendage closure technologyLucas V A Boersma, Boris Schmidt, Tim R Betts, et al.
The Journal of Invasive Cardiology|June 27, 2024
ALSTER-TAVR 2024: clinical results at one year following optimized self-expanding, transcatheter aortic valve peplacement employing the cusp-overlay techniqueMartin W Bergmann, Janina Maren Krause, Niklas Schofer, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 30, 2014
Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity systemLukas Kaiser, Thomas Beister, Andrea Wiese, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
JACC. Case Reports|January 17, 2022
Atrial Giant Cell Myocarditis as a Cause of Heart Failure: Diagnostic Pathway and Successful TreatmentChristina Paitazoglou, Martin W Bergmann, Katharina Tiemann, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 3, 2014
Twelve-month results of the rapid renal sympathetic denervation for resistant hypertension using the OneShotTM ablation system (RAPID) studyStefan Verheye, John Ormiston, Martin W Bergmann, et al.
The Journal of Invasive Cardiology|July 2, 2017
Improved Algorithm for Ostium Size Assessment in Watchman Left Atrial Appendage Occlusion Using Three-Dimensional EchocardiographyMaximilian Schmidt-Salzmann, Felix Meincke, Felix Kreidel, et al.
American Heart Journal|June 20, 2017
The Assessment of the Watchman Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO) trialDavid R Holmes, Vivek Y Reddy, Maurice Buchbinder, et al.
The Biochemical Journal|January 27, 2010
Glucocorticoids inhibit IL-1beta-induced GM-CSF expression at multiple levels: roles for the ERK pathway and repression by MKP-1Robert Newton, Elizabeth M King, Wei Gong, et al.
JACC. Heart Failure|January 5, 2024
Treatment With an Interatrial Shunt in Heart Failure: 1-Year Outcomes of the PRELIEVE StudyChristina Paitazoglou, Martin W Bergmann, Baris Kilicaslan, et al.
European Journal of Heart Failure|December 22, 2009
MEF2 transcriptional activity maintains mitochondrial adaptation in cardiac pressure overloadHamid el Azzouzi, Ralph J van Oort, Roel van der Nagel, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 1, 2016
EWOLUTION: Design of a registry to evaluate real-world clinical outcomes in patients with AF and high stroke risk-treated with the WATCHMAN left atrial appendage closure technologyLucas V A Boersma, Boris Schmidt, Tim R Betts, et al.
The Journal of Invasive Cardiology|June 27, 2024
ALSTER-TAVR 2024: clinical results at one year following optimized self-expanding, transcatheter aortic valve peplacement employing the cusp-overlay techniqueMartin W Bergmann, Janina Maren Krause, Niklas Schofer, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 30, 2014
Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity systemLukas Kaiser, Thomas Beister, Andrea Wiese, et al.
Pageof 10